Skip to main content
Skip to footer
Home
News Channels
Antibodies
Proteins and Peptides
Vaccines
DNA RNA and Cells
Small Molecules
More News
All News
Reports
Press Room
Contact Us
About Us
All Categories
Antibodies
DNA RNA and Cells
More News
Proteins and Peptides
Small Molecules
Vaccines
Any Word
All Words
Exact Phrase
Reports
Mar 2025
Competitor Analysis: PSMA-Targeted Therapy & Radiodiagnostics
500,00€
Mar 2025
2024 Sales of Therapeutic Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and Therapeutic RNA
130,00€
Feb 2025
PD-1 x VEGF and PD-L1 x VEGF bispecific antibodies: a business, pipeline and competitor analysis from an industry perspective
2.000,00€
Sep 2024
Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective
2.050,00€
Aug 2024
CD47 and SIRP-alpha Targeted Immunotherapy Pipeline Review
400,00€
Aug 2024
B7-H4 Targeted Antibody Therapy Pipeline Review
200,00€
Jul 2024
Tocilizumab (Actemra/RoActemra) Biosimilar Antibody Pipeline Review
200,00€
Jul 2024
PD-L1 x 4-1BB (CD137) Bispecific Antibody Pipeline Review
200,00€
Jul 2024
Pembrolizumab (Keytruda) Biosimilar Antibody Pipeline Review
200,00€
Apr 2024
CD73 Inhibitor Pipeline Review
200,00€
Apr 2024
Claudin 18.2-Targeted Immunotherapeutics – a Competitor Analysis
430,00€
Apr 2024
Report Package: Claudin 18.2-Targeted Immunotherapeutics
2.150,00€
Mar 2024
CD38-Targeted Antibody & Cell Therapy Pipeline Review
300,00€
Mar 2024
TL1A Inhibitor Pipeline Review
100,00€
Mar 2024
5T4-Targeted Immunotherapy Candidates Pipeline Review
100,00€
Mar 2024
2023 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics
130,00€
Mar 2024
Biologics Sales Database for Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and RNA
250,00€
Jan 2024
GPC3-Targeted Immunotherapy Pipeline Review
300,00€
Jan 2024
Her3-Targeted Immunotherapy Pipeline Review
300,00€
Jan 2024
TROP-2-Targeted Immunotherapy Pipeline Review
300,00€
Jan 2024
Nectin-4-Targeted Immunotherapy Pipeline Review
200,00€
Nov 2023
DLL3-Targeted Immunotherapy Candidates Pipeline Review
200,00€
Nov 2023
B7-H3-Targeted Immunotherapy Candidates Pipeline Review
300,00€
Oct 2023
EpCAM-Targeted Antibodies Pipeline Review
200,00€
Oct 2023
PD-1 Agonists Pipeline Review
200,00€
1
2
3
→
Any Word
All Words
Exact Phrase
Report categories
Antibody & Protein Sales
Antibody Technologies
Biosimilar Antibodies & Proteins
CAR T-Cells
Drug the Undruggable Technologies
Immuno-Oncology
mRNA Vaccines & Therapeutics
NK Cells & CAR Macrophages
Pipeline Database
RNA-Targeted Therapeutics
Target Pipelines
TCR T-Cells and Antibodies
Therapeutic Antibodies
Therapeutic Proteins & Peptides
2023 Sales of
Antibodies & Proteins
Get it now.
